Form 4: Coherent Corp. Director's Stock Grant & New Legal Appointments
Insider Transaction Report and Administrative Update
Coherent Corp. director Enrico Digirolamo received a restricted stock unit award, while new substitute attorneys-in-fact were appointed for Section 16 filings.
Summary
- Enrico Digirolamo, a Director of Coherent Corp. (COHR), was granted 2,272 shares of common stock as a restricted stock unit award on August 28, 2025.
- These shares were acquired at a price of $0 and are scheduled to vest on August 28, 2026.
- Following this transaction, Mr. Digirolamo beneficially owns 23,909 shares of Coherent Corp. common stock.
- Jeffrey W. Acre appointed Aaron Wax, Chris Forrester, and Yian Huang as substitute attorneys-in-fact, effective March 18, 2025.
- These substitute attorneys are authorized to execute Forms 3, 4, and 5 on behalf of several individuals, including Enrico Digirolamo, for Section 16(a) of the Securities Exchange Act of 1934.
Sentiment
Score: 7
Explanation: The filing primarily consists of routine administrative updates regarding powers of attorney and a standard restricted stock unit grant to a director, which is generally viewed as a positive for aligning management incentives with shareholder interests.
Positives
- The grant of restricted stock units to a director aligns management's interests with shareholders.
- The vesting schedule provides an incentive for long-term performance and retention of the director.
Future Outlook
The vesting of the restricted stock units on August 28, 2026, indicates a future milestone for the director's compensation.
Industry Context
Restricted stock unit grants are a common form of executive and director compensation in publicly traded companies, aligning interests with long-term shareholder value. The appointment of substitute attorneys-in-fact is a standard administrative procedure for managing SEC reporting obligations for insiders.
Comparison to Industry Standards
- RSU grants are a standard compensation practice across industries for directors and executives, promoting long-term alignment. The specific number of shares (2,272) and the total beneficial ownership (23,909) would need to be compared against similar-sized companies in the materials or photonics industry to assess if it's within typical ranges, but the filing itself does not provide this comparative data.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Substitute Attorney-in-Fact | Jeffrey W. Acre (as appointing party) | Aaron Wax, Chris Forrester, Yian Huang | March 18, 2025 | Delegation of authority for Section 16 filings |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Appointment of Aaron Wax, Chris Forrester, and Yian Huang as substitute attorneys-in-fact to execute Section 16 filings (Forms 3, 4, and 5) for specified individuals. | March 18, 2025 | Enhances administrative efficiency and ensures compliance with SEC reporting requirements for insiders. |
Stakeholder Impact
- Shareholders: The RSU grant aligns director interests with long-term shareholder value. The administrative updates ensure proper regulatory compliance.
Next Steps
- Vesting of Enrico Digirolamo's restricted stock units on August 28, 2026.
Key Dates
| Date | Description |
|---|---|
| March 18, 2025 | Effective date of Substitute Power of Attorney. |
| August 28, 2025 | Date of transaction for Enrico Digirolamo's restricted stock unit award. |
| September 2, 2025 | Date of signature for the Form 4 filing by the attorney-in-fact. |
| August 28, 2026 | Vesting date for Enrico Digirolamo's restricted stock unit award. |
Recommendation
holdThe filing contains routine administrative updates and a standard director compensation grant. There is no new information that would significantly alter the investment thesis or warrant a change in an existing position.
Keywords
Coherent Corp, COHR, SEC filing, Form 4, Section 16, insider trading, beneficial ownership, restricted stock units, RSU, director compensation, power of attorney, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.